Terug
Dagbereik
€ 8,28
€ 8,70
52-Weeksbereik
€ 7,48
€ 31,18
Volume
2.285.970
50D / 200D Gem.
€ 11,31
/
€ 13,04
Vorige Slotkoers
€ 8,74
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,2 | 0,3 |
| P/B | 17,1 | 2,9 |
| ROE % | -310,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 5,4 | 0,2 |
Koersdoel Analisten
Hold
€ 21,29
+153.8%
Low: € 10,00
High: € 42,00
Forward WPA
-€ 2,98
Omzet Sch.
2,5 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,26
€ 0,05 – € 0,72
|
780 M | 4 |
| FY2029 |
-€ 1,47
-€ 4,13 – -€ 0,30
|
330 M | 4 |
| FY2028 |
-€ 2,25
-€ 4,07 – -€ 0,10
|
110 M | 11 |
Belangrijkste Punten
Debt/Equity of 5,36 — high leverage
Negative free cash flow of -610,15M
PEG of 0,06 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-310,75%
ROIC-168,93%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
5,36
Current Ratio3,18
Interest Coverage0,00
Waardering
P/E Ratio
-1,20
P/B Ratio17,06
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -738,82M |
| ROE | -310,75% | ROA | -163,66% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -610,15M |
| ROIC | -168,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5,36 | Current Ratio | 3,18 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -1,20 | P/B Ratio | 17,06 |
| P/S Ratio | N/A | PEG Ratio | 0,06 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 888,21M | Enterprise Value | 937,11M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -738,82M | -846,42M | -408,17M | -570,28M | -213,80M |
| EPS (Diluted) | -6,86 | -9,28 | -5,73 | -12,75 | -5,97 |
| Gross Profit | -4,14M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -745,38M | -885,11M | -436,05M | -567,93M | -218,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 451,45M | 615,11M | 513,21M | 661,78M | 142,06M |
| Total Liabilities | 399,38M | 191,67M | 85,24M | 123,01M | 47,37M |
| Shareholders' Equity | 52,07M | 423,44M | 427,98M | 538,77M | 34,69M |
| Total Debt | 278,86M | 36,58M | 30,88M | 33,60M | 3,24M |
| Cash & Equivalents | 229,96M | 99,13M | 248,40M | 204,88M | 76,06M |
| Current Assets | 368,33M | 538,47M | 442,45M | 586,97M | 94,82M |
| Current Liabilities | 115,93M | 154,23M | 55,42M | 90,02M | 41,94M |